Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.. |
Info | Profile |
---|---|
Name | Ikapharmindo Putramas Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 12/31/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Ikapharma Inti Mas | 78.12 | 78.12 |
Public < 5% | 20.0 | 20.0 |
Dra. Maudy Ratna Winata | 0.88 | 0.88 |
Drs. Titianus Winata | 0.62 | 0.62 |
Augustina Winata | 0.19 | 0.19 |
Eliza Arlena Winata | 0.19 | 0.19 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 78.12 | 78.12 |
Retail | 20.0 | 20.0 |
Management | 1.69 | 1.69 |
Individual | 0.19 | 0.19 |
Revenue Source | 2023 | 2022 |
---|
Revenue Region | 2023 | 2022 |
---|
Year | DPS | Yield [%] |
---|---|---|
2024 | 2.2 | 1.0 |
Timeframe | Performance |
---|---|
1W % | -4.2 |
1Mo % | 3.6 |
3Mo % | -6.6 |
1Yr % | 0.4 |
Pivot | Points |
---|---|
R2 | 286 |
R1 | 262 |
S1 | 212 |
S2 | 186 |
Link download Laporan Keuangan emiten
Stock | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
IKPM | 77.29 | 398 B | 619 B | 412 B | 26 B | 5 B |
KLBF | 21.78 | 58.13 T | 58.24 T | 32,628 B | 5,069 B | 3,241 B |
SIDO | 13.45 | 17.40 T | 16.99 T | 3,919 B | 1,577 B | 1,171 B |
TSPC | 7.93 | 11.95 T | 10.82 T | 13,655 B | 2,114 B | 1,448 B |
SOHO | 18.53 | 8.25 T | 10.52 T | 10,058 B | 618 B | 463 B |
KAEF | -4.88 | 2.39 T | 12.98 T | 10,486 B | -9 B | -562 B |